- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
GCVI Summit 2021 review
For many of the attendees at the Global Corporate Venturing and Innovation Summit 2021 held late last month in Monterey, California, the conference was their first in-real life (IRL) event since the pandemic effectively stopped them in the first quarter last year after the previous summit.
Oct 19, 2021Daily Deal Round Up: October 18, 2021
Corporate-backed communications monetisation technology developer Matrixx Software raised $50m from Francisco Partners while cancer drug developer Abalos took the same in a BIVF-backed round.
Oct 18, 2021WBA expands presence in VillageMD in $5.2bn deal
The pharmacy operator more than doubled its stake in the primary care provider and now plans to accelerate a co-location rollout plan.
Oct 18, 2021PharmEasy reaps $350m pre-IPO funding
The Ascent Health and Wellness Solutions, Manipal Education and Medical Group, Medi Assist Healthcare Services and Prosus-backed online drugstore secured the funding at a $5.6bn valuation.
Oct 18, 2021Lark treats itself to $100m
The Omron-backed preventative healthcare provider will use the series D funding to bolster research and development and expand its customer base.
Oct 18, 2021Trumid raises $208m
Bond trading platform developer Trumid raised its latest round, featuring Singapore Exchange, at a $2.4bn valuation. This is one of the latest examples of such multi-million dollar deals from the roaring fintech space.
Oct 17, 2021Daily deal net: October 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 15, 2021Daily Deal Round Up: October 14, 2021
Neurological disease drug developer Axial raised $37.3m from investors including Taiho Ventures while Best Buy is purchasing OSF and Legal & General-backed remote healthcare technology provider Current Health.
Oct 14, 2021CinCor Pharma bags $143m
Eli Lilly participated in a series B round for the cardiorenal treatment specialist that will support clinical drug trials, boosting its overall funding to $193m.
Oct 14, 2021Sciwind Biosciences slides in $70m
Legend Holdings and Kawin Technology-backed Sciwind topped up its coffers in a series C round to advance its metabolic disease drug pipeline.
Oct 14, 2021Daily Deal Round Up: October 13, 2021
Singtel Innov8 is set to exit cybersecurity technology developer Bitglass in an acquisition deal while Nio Capital contributed to marketing software developer Whale's $50m series B round.
Oct 13, 2021Entrada Therapeutics files for Nasdaq Listing
The Duchenne muscular dystrophy drug developer's initial public offering could prove an exit ramp for Roche and Merck & Co.
Oct 13, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
